These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 7012807)

  • 1. [Decaris - a drug from the immunomodulator group - in the treatment of recurrent aphthous stomatitis].
    Górska R
    Pol Tyg Lek; 1980 Nov; 35(45):1751-3. PubMed ID: 7012807
    [No Abstract]   [Full Text] [Related]  

  • 2. Levamisole in the treatment of recurrent aphthous stomatitis.
    Van de Heyning J
    Laryngoscope; 1978 Mar; 88(3):522-7. PubMed ID: 342850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levamisole in recurrent aphthous stomatitis.
    Dash R; Panda R; Mishra SS; Das PC; Mishra KC
    J Indian Med Assoc; 1983 May; 80(9-10):140-1. PubMed ID: 6644050
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of recurrent herpes simplex and recurring stomatitis with levamisol].
    Luderschmidt C
    Z Hautkr; 1979 May; 54(10):421-3. PubMed ID: 473837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of recurrent aphthae with levamisol].
    Zheng JL
    Zhonghua Kou Qiang Ke Za Zhi; 1982 Jun; 17(2):78-80. PubMed ID: 6959786
    [No Abstract]   [Full Text] [Related]  

  • 6. Levamisole can modulate the serum tumor necrosis factor-alpha level in patients with recurrent aphthous ulcerations.
    Sun A; Wang JT; Chia JS; Chiang CP
    J Oral Pathol Med; 2006 Feb; 35(2):111-6. PubMed ID: 16430742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunomodulating treatment with levamisole in recurrent ulcero-aphthous stomatitis].
    Sasu P; Acalovschi R
    Rev Pediatr Obstet Ginecol Pediatr; 1987; 36(3):281-4. PubMed ID: 3120282
    [No Abstract]   [Full Text] [Related]  

  • 8. [Levamisole - a new treatment for two old problems: recurrent aphthous ulceration and recurrent labial herpes simplex].
    Machado JA
    Rev Assoc Paul Cir Dent; 1981; 35(1):20-6. PubMed ID: 6943614
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical effect of levamisole therapy and its immunological control.
    Husz S; Hunyadi J; Berkó G; Dobozy A; Kenderessy A; Simon N
    Dermatol Monatsschr; 1979 Aug; 165(8):569-74. PubMed ID: 229002
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experience in treating patients with recurrent aphthous stomatitis with dekaris].
    Abramova EI; Liubomirova IM
    Stomatologiia (Mosk); 1986; 65(4):29-30. PubMed ID: 3462976
    [No Abstract]   [Full Text] [Related]  

  • 11. [Kemantan treatment of patients with recurrent aphthous stomatitis].
    Terekhova NV; Khazanova VV; Zemskaia EA; Kosorukova NIa; Bykova IA; Zidra SI
    Stomatologiia (Mosk); 1990; 69(1):31-3. PubMed ID: 2326807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the therapeutic effect of levamisole in treatment of recurrent aphthous stomatitis.
    Gier RE; George B; Wilson T; Rueger A; Hart JK; Quaison F; Hardman PK
    J Oral Pathol; 1978; 7(6):405-13. PubMed ID: 105100
    [No Abstract]   [Full Text] [Related]  

  • 13. [Decaris in the treatment of patients with recurrent aphthae].
    Gawrzewska B; Knychalska-Karwan Z; Kucharska M; Skotnicki A
    Czas Stomatol; 1984 Jan; 37(1):85-91. PubMed ID: 6590253
    [No Abstract]   [Full Text] [Related]  

  • 14. [Levamisole and its use in dermatologic therapy].
    Marcyniak-Górska M
    Przegl Dermatol; 1983; 70(5-6):563-8. PubMed ID: 6366926
    [No Abstract]   [Full Text] [Related]  

  • 15. Double-blind study of levamisole in aphthous stomatitis.
    Kaplan B; Cardarelli C; Pinnell SR
    J Oral Pathol; 1978; 7(6):400-4. PubMed ID: 105099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic evaluation of levamisole in recurrent aphthous stomatitis. Double-blind comparison of two dosage schedules of levamisole and placebo.
    Zissis NP; Hatzioti AJ; Antoniadis D; Ninika A; Hatziotis JC
    J Oral Med; 1983; 38(4):161-3. PubMed ID: 6366166
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical and MRI characteristics of levamisole-induced leukoencephalopathy in 16 patients.
    Xu N; Zhou W; Li S; Zhou G; Zhang N; Liang J
    J Neuroimaging; 2009 Oct; 19(4):326-31. PubMed ID: 19187474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [T-activin in the treatment of patients with recurrent aphthous stomatitis].
    Terekhova NV; Khazanova VV; Zemskaia EA; Bykova IA; Filonenko OF; Kosorukova NIa; Rabinovich IM
    Stomatologiia (Mosk); 1991; (2):35-7. PubMed ID: 1853375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukoencephalopathy induced by levamisole alone for the treatment of recurrent aphthous ulcers.
    Liu HM; Hsieh WJ; Yang CC; Wu VC; Wu KD
    Neurology; 2006 Sep; 67(6):1065-7. PubMed ID: 17000980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized double-blind trial of levamisole in the therapy of recurrent aphthous stomatitis.
    De Cree J; Verhaegen H; De Cock W; Verbruggen F
    Oral Surg Oral Med Oral Pathol; 1978 Mar; 45(3):378-84. PubMed ID: 345174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.